Lynette R. Moser

604 total citations
24 papers, 425 citations indexed

About

Lynette R. Moser is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Lynette R. Moser has authored 24 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 5 papers in Internal Medicine. Recurrent topics in Lynette R. Moser's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Lynette R. Moser is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Lynette R. Moser collaborates with scholars based in United States, Belgium and Germany. Lynette R. Moser's co-authors include Christopher Giuliano, Candice L. Garwood, Mark Munger, Helen Berlie, Jennifer L. Johnson, George P. Allen, Usha Sambamoorthi, Kathryn A. Morbitzer, Karleen S. Callahan and Gregory J. Stoddard and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Obstetrics and Gynecology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Lynette R. Moser

23 papers receiving 403 citations

Peers

Countries citing papers authored by Lynette R. Moser

Since Specialization

Citations

This map shows the geographic impact of Lynette R. Moser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynette R. Moser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynette R. Moser more than expected).

Fields of papers citing papers by Lynette R. Moser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynette R. Moser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynette R. Moser. The network helps show where Lynette R. Moser may publish in the future.

Co-authorship network of co-authors of Lynette R. Moser

This figure shows the co-authorship network connecting the top 25 collaborators of Lynette R. Moser. A scholar is included among the top collaborators of Lynette R. Moser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynette R. Moser. Lynette R. Moser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A multimodal interprofessional education program including case-based problem solving focused on pain management increases student’s knowledge and interprofessional skills 2022 ·Journal of Interprofessional Care ·Candice L. Garwood, (unknown), (unknown), (unknown), Lynette R. Moser, (unknown), (unknown)	5
2	Team-based Learning to Promote the Development of Metacognitive Awareness and Monitoring in Pharmacy Students 2020 ·American Journal of Pharmaceutical Education ·(unknown), Lynette R. Moser	15
3	Understandability, actionability, and readability of online patient education materials about diabetes mellitus 2019 ·American Journal of Health-System Pharmacy ·(unknown), Helen Berlie, (unknown), (unknown), Lynette R. Moser	66
4	Clinical Outcomes of Student Pharmacist–Driven Medication Histories at an Academic Medical Center 2018 ·Journal of Pharmacy Practice ·(unknown), Lynette R. Moser, (unknown), (unknown)	6
5	Anticoagulation Bridge Therapy in Patients with Atrial Fibrillation: Recent Updates Providing a Rebalance of Risk and Benefit 2017 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Candice L. Garwood, (unknown), (unknown), (unknown), (unknown), Lynette R. Moser	17
6	Evaluation of a Flipped Drug Literature Evaluation Course 2016 ·American Journal of Pharmaceutical Education ·Christopher Giuliano, Lynette R. Moser	52
7	The Role of Servant Leadership and Transformational Leadership in Academic Pharmacy 2016 ·American Journal of Pharmaceutical Education ·George P. Allen, (unknown), Lynette R. Moser, (unknown), Usha Sambamoorthi, (unknown)	46
8	Enhancing Academic Success by Creating a Community of Learners 2015 ·American Journal of Pharmaceutical Education ·Lynette R. Moser, Helen Berlie, (unknown), (unknown), Richard L. Slaughter	13
9	Project ImPACT: Hypertension Outcomes of a Pharmacist-Provided Hypertension Service 2013 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Lynette R. Moser	5
10	Use of Prolonged Bivalirudin Infusions Following Percutaneous Coronary Intervention 2011 ·Cardiovascular Drugs and Therapy ·Lynette R. Moser, (unknown), (unknown)	1
11	Striking a Balance Between the Risks and Benefits of Anticoagulation Bridge Therapy in Patients with Atrial Fibrillation: Clinical Updates and Remaining Controversies 2011 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Candice L. Garwood, (unknown), Lynette R. Moser	9
12	Mitomycin-C and 5-Fluoro-Uracil Containing Chemotherapy With Concurrent Hyperfractionated Accelerated RadioTherapy (C-HART) of 70.6 Gy Is More Effective than Dose Escalated HART of 77.6 Gy Alone–10 Year Results of the German Multicenter Phase III Randomized Trial (ARO 95-06) 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Volker Budach, (unknown), Michaël Baumann, W. Budach, Gerhard G. Grabenbauer, Lynette R. Moser, Peter Wust, (unknown), Kristoph Jahnke, K. D. Wernecke	2
13	Glycoprotein IIb/IIIa Receptor Antagonists and Risk of Bleeding: A Single‐Center Experience in 1020 Patients 2004 ·The Journal of Clinical Pharmacology ·Arshad Ali, Mustafa Hashem, Howard Rosman, Lynette R. Moser, (unknown), Thomas P. Davis, (unknown), Thomas LaLonde, Hiroshi Yamasaki, (unknown), (unknown), (unknown), Theodore Schreiber, Julius M. Gardin	13
14	Role of Low-Molecular-Weight Heparin in Invasive Management of Non–ST-Elevation Acute Coronary Syndromes 2004 ·Annals of Pharmacotherapy ·Lynette R. Moser, James S. Kalus	0
15	Eptifibatide and risk of bleeding after failed thrombolysis. 2004 ·PubMed ·Arshad Ali, (unknown), (unknown), (unknown), Lynette R. Moser, Thomas P. Davis, (unknown), Thomas LaLonde, Theodore Schreiber	2
16	The Use of Calcium Salts in the Prevention and Management of Verapamil-Induced Hypotension 2000 ·Annals of Pharmacotherapy ·Lynette R. Moser, Maureen A. Smythe, James E. Tisdale	8
17	ACE Inhibitor Effects on Platelet Function in Stages I-II Hypertension 1997 ·Journal of Cardiovascular Pharmacology ·Lynette R. Moser, Karleen S. Callahan, Alfred K. Cheung, Gregory J. Stoddard, Mark Munger	24
18	Fatality Due to Intravenous Diltiazem for Acute Ventricular Rate Control 1996 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Lynette R. Moser, Edward A. Panacek, Mark Munger	3
19	Presence of azithromycin breast milk concentrations: A case report 1994 ·American Journal of Obstetrics and Gynecology ·(unknown), Lynette R. Moser, (unknown), Mark Munger	32
20	Presence of azithromycin breast milk concentrations: A case report 1994 ·American Journal of Obstetrics and Gynecology ·(unknown), Lynette R. Moser, (unknown), Mark Munger	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact